Pazopanib for second recurrence of osteosarcoma in pediatric patients

Pediatr Int. 2017 Aug;59(8):937-938. doi: 10.1111/ped.13307. Epub 2017 Jul 6.

Authors

Katsutsugu Umeda¹, Itaru Kato¹, Satoshi Saida¹, Takeshi Okamoto², Souchi Adachi³

Affiliations

¹ Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
³ Department of Human Health Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

PMID: 28685501
DOI: 10.1111/ped.13307

No abstract available

Keywords: osteosarcoma; pazopanib; pediatric; recurrence; tyrosine kinase inhibitor.

Publication types

Case Reports

MeSH terms

Adolescent
Angiogenesis Inhibitors / therapeutic use*
Bone Neoplasms / pathology*
Child
Female
Humans
Indazoles
Liver Neoplasms / drug therapy
Liver Neoplasms / secondary*
Lung Neoplasms / drug therapy
Lung Neoplasms / secondary*
Male
Osteosarcoma / drug therapy
Osteosarcoma / secondary*
Pyrimidines / therapeutic use*
Sulfonamides / therapeutic use*

Substances

Angiogenesis Inhibitors
Indazoles
Pyrimidines
Sulfonamides
pazopanib